192 - An Update on COVID-19 Treatments: Monoclonal Antibodies, Convalescent Plasma, Remdesivir and More

from Public Health On Call · host Johns Hopkins Bloomberg School of Public Health

COVID-19 mortality rates are falling and better treatments are one of the main reasons why. Dr. Arturo Casadevall returns to the podcast to talk with Stephanie Desmon about where we are with different treatments and their successes, ongoing clinical trials, why some treatments are harder than others to produce, and whether we'll continue to see investments in treatments when a vaccine is available. KEYWORDS: COVID-19 therapy; vaccine authorization; immune response

Episode metadata supplied by the publisher feed · Published Nov 2, 2020

Embed this episode

Attribution link and audio player

Ready to play

192 - An Update on COVID-19 Treatments: Monoclonal Antibodies, Convalescent Plasma, Remdesivir and More

0:00 15:10

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Public Health On Call?

This episode is 15 minutes long.

When was this Public Health On Call episode published?

This episode was published on November 2, 2020.

Can I download this Public Health On Call episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!